Edwards Lifesciences Corporatio (NYSE:EW)

WEB NEWS

Tuesday, February 3, 2009

Comments & Business Outlook

Guidance Report: (Non-China)

Full Year Fiscal 2009 Guidance Ending December

2009 Revenue Guidance 2008 Revenue Period Change in Revenue 2009 EPS Guidance 2008 EPS Period Change in EPS
$1.24 to $1.30 billion $1.24 billion 10% to 12% $2.93 to $3.03 $2.55 15% to 19%

EPS Figures exclude non-operating gains and losses (Non-GAAP).

"We look forward to continuing this momentum in 2009, with expectations of strong earnings growth even while we increase R&D investments by more than 20 percent," said Mussallem.

Source: Marketwire (February 3, 2009) 

 



Market Data powered by QuoteMedia. Terms of Use